abstract |
The invention discloses optically pure adrenergic β2 receptor agonist R-enantiomer (including R-salbutamol, R-terbutaline, R-clenbuterol and R-bambuterol) for the treatment of inflammatory diseases New applications in enteropathy and extraintestinal diseases including skin diseases. |